HEATHER MITCHELL: Open Payments
NPI 1326278466 · LOUISBURG, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$819 in 42 payments from 11 companies in 2025. Trend: 2023 $506 · 2024 $1,008 · 2025 $819
Food & beverage: $819
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $174 |
| ABBVIE INC. | 10 | $172 |
| AstraZeneca Pharmaceuticals LP | 6 | $139 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $89 |
| GlaxoSmithKline, LLC. | 3 | $65 |
| Amgen Inc. | 3 | $43 |
| Exact Sciences Corporation | 2 | $37 |
| Lilly USA, LLC | 2 | $33 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Abbott Laboratories | 1 | $26 |
Products named: BREZTRI, CAPLYTA, Ozempic, VRAYLAR, TRELEGY ELLIPTA, QULIPTA, OTEZLA, The Cologuard Plus Collection Kit.
Industry payments across NC — which companies pay providers there.
